Why the study?
Are serum lipids, cholinesterase, and apolipoproteins effective in discriminating between patients with atherosclerotic diseases and healthy subjects?
Are serum lipids, cholinesterase, and apolipoproteins effective in discriminating between patients with atherosclerotic diseases and healthy subjects?
Answers are grounded in this paper and cite their sources.
Apolipoprotein measurements, particularly Apo A-I/Apo B ratios, are highly effective in discriminating between patients with cardiovascular or cerebrovascular atherosclerosis and healthy individuals.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kawamoto et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: